Dr. Claudio Brunstein has published the results of a recent University of Minnesota study of 65 patients with lymphoid malignancies. Each patient had nonmyeloablative conditioning followed by umbilical cord blood transplantation. The study found that three years post-transplant, this patient group had low treatment related mortality (TRM). A sizeable proportion of these patients also enjoyed prolonged progression-free survival (PFS) and overall survival (OS).

Dr. Brunstein has previously published his findings about the use of nonmyeloablative UCB transplantation in adult patients with advanced hematological diseases.

For more information about this study, click on this link to the abstract in Biology of Blood and Marrow Transplant.